Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Armata Pharmaceuticals Inc (ARMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Armata Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.220 -0.030    -0.71%
12/08 - Closed. Currency in USD ( Disclaimer )
After Hours
4.250
+0.050
+1.190%
18:30:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 222
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 4.220 - 4.220
Armata Pharma 4.220 -0.030 -0.71%

Armata Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 9.22 million compared to USD 6.19 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.25 a year ago. Diluted loss per share from continuing operations was USD 0.26 compared to USD 0.25 a year ago.For the six months, net loss was USD 17.99 million compared to USD 11.69 million a year ago. Basic loss per share from continuing operations was USD 0.55 compared to USD 0.52 a year ago. Diluted loss per share from continuing operations was USD 0.55 compared to USD 0.52 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ARMP Income Statement

Gross margin TTM -273.48%
Operating margin TTM -563.28%
Net Profit margin TTM -549.64%
Return on Investment TTM -38.32%
 Total Revenue  Net Income
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Revenue 1.88 1.24 0.99 1.25
Gross Profit 1.88
Operating Income -9.22 -8.78 -6.05 -5.42
Net Income -9.22 -8.77 -6.05 -5.42

ARMP Balance Sheet

Quick Ratio MRQ 5.01
Current Ratio MRQ 5.59
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 73.07%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Assets 100.98 107.77 69.77 42.67
Total Liabilities 47.69 46.23 44.37 18.92
Total Equity 53.29 61.54 25.4 23.75

ARMP Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -110.43%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Period Length: 0 Months 3 Months 12 Months 9 Months
Cash From Operating Activities -8.15 -3.52 -23.57 -14.98
Cash From Investing Activities -1.14 -0.24 -1.3 -1.08
Cash From Financing Activities -0.146 44.63 25.52 18.48
Net Change in Cash -9.43 40.88 0.64 2.43
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARMP Comments

Write your thoughts about Armata Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
John Simmons Simmons
John Simmons Simmons Apr 01, 2020 9:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do you think Armata will go higher than 8 usd ?
Jj Jj
Jj Jj Jan 29, 2018 3:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cheap now and will go higher ^|^
Jj Jj
Jj Jj Jan 04, 2018 2:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This gonna be $30 in 6 montbs
Bahadır Ekinci
Bahadır Ekinci Jan 04, 2018 2:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
? ?
Unknown you
Unknown you Jan 04, 2018 2:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are funny
Jade Krogh
Jade Krogh Dec 14, 2017 9:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For the last half-century, antibiotics have been the backbone for the treatment of infections in modern medicine.. . Across the years, though, our over-reliance on these drugs has backfired. The sweeping use of antibacterial drugs has sparked an evolutionary arms race between us and bacteria... and we're rapidly falling behind.. . In 1945, Alexander Fleming won a Nobel Prize for the discovery of penicillin. In that very acceptance speech, he warned us of exactly what's occurring today: The selective pressure caused by antibiotics would result in so-called “superbugs” that we would no longer be able to contain.. . To get an example of just how serious this issue has become, consider the following:. . In 2014, there were ~450,000 new cases of multi-drug-resistant tuberculosis (MDR-TB).. Full resistance to last-resort treatments for gonorrhea and TB have now been reported in over 10 countries, including many with advanced health care systems, such as Australia, Canada, France, Sweden, and Britain.
Hingle McCringleberry
Hingle McCringleberry Dec 29, 2016 9:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
who's coming with me?
Hingle McCringleberry
Hingle McCringleberry Dec 29, 2016 9:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
who's coming with me?
Matt Stafford
Matt Stafford Dec 29, 2016 9:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm with ya
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email